APO Research
Talk to an analyst

APO RESEARCH · REPORT

β-Nicotinamide Mononucleotide (NMN)

β-Nicotinamide Mononucleotide (NMN) is a form of nicotinamide mononucleotide (NMN) that exists in two stereoisomeric forms: α-NMN and β-NMN. NMN is a nucleotide derived from nicotinamide (vitamin B3) and ribose. It serves as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme found in all living cells.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

β-Nicotinamide Mononucleotide (NMN) is a form of nicotinamide mononucleotide (NMN) that exists in two stereoisomeric forms: α-NMN and β-NMN. NMN is a nucleotide derived from nicotinamide (vitamin B3) and ribose. It serves as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme found in all living cells.

NAD+ plays a crucial role in various cellular processes, including energy metabolism, DNA repair, gene expression, and cell signaling. As individuals age, NAD+ levels tend to decline, which is believed to contribute to age-related health issues. Supplementing with NMN is thought to boost NAD+ levels in cells, potentially slowing down the aging process and improving overall health.

β-NMN specifically refers to the beta form of NMN. While both α-NMN and β-NMN are biologically active, research suggests that β-NMN may have better stability and bioavailability compared to α-NMN. Therefore, β-NMN is often the preferred form used in research and supplementation.

Selected research

Market Analysis & Forecast

Global β-Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032

27 December 2025217 pages

Choose your research edition.

Industry Researchβ-Nicotinamide Mononucleotide (NMN) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal β-Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal β-Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal β-Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal β-Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

β-Nicotinamide Mononucleotide (NMN) is a form of nicotinamide mononucleotide (NMN) that exists in two stereoisomeric forms: α-NMN and β-NMN. NMN is a nucleotide derived from nicotinamide (vitamin B3) and ribose. It serves as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme found in all living cells.

NAD+ plays a crucial role in various cellular processes, including energy metabolism, DNA repair, gene expression, and cell signaling. As individuals age, NAD+ levels tend to decline, which is believed to contribute to age-related health issues. Supplementing with NMN is thought to boost NAD+ levels in cells, potentially slowing down the aging process and improving overall health.

β-NMN specifically refers to the beta form of NMN. While both α-NMN and β-NMN are biologically active, research suggests that β-NMN may have better stability and bioavailability compared to α-NMN. Therefore, β-NMN is often the preferred form used in research and supplementation.

Read the full market overview

The global β-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

β-Nicotinamide Mononucleotide (NMN)'s global sales reached XX (Kg) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned GeneHarbor as the global sales leader, a title it has maintained for several consecutive years. Notably, GeneHarbor's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Kg), a change of XX% from the previous year. In Europe, sales were XX (Kg), showing a year-on-year of XX%. In the US, sales were XX (Kg), a year-on-year change of XX%.

The major global manufacturers in the β-Nicotinamide Mononucleotide (NMN) market include GeneHarbor, Herbalmax, Genex Formulas, MIRAILAB BIOSCIENCE Inc, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the β-Nicotinamide Mononucleotide (NMN) production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of β-Nicotinamide Mononucleotide (NMN) by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for β-Nicotinamide Mononucleotide (NMN), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of β-Nicotinamide Mononucleotide (NMN), also provides the consumption of main regions and countries. Of the upcoming market potential for β-Nicotinamide Mononucleotide (NMN), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the β-Nicotinamide Mononucleotide (NMN) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global β-Nicotinamide Mononucleotide (NMN) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for β-Nicotinamide Mononucleotide (NMN) sales, projected growth trends, production technology, application and end-user industry.

β-Nicotinamide Mononucleotide (NMN) Segment by Company

GeneHarbor

Herbalmax

Genex Formulas

MIRAILAB BIOSCIENCE Inc

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Oriental Yeast

Blue California (Conagen)

Borealis Pharma B.V. (Longevir®)

Hi-Tech Pharmaceuticals

β-Nicotinamide Mononucleotide (NMN) Segment by Type

Content Greater than or Equal to 98%

Content Less than 98%

β-Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

β-Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global β-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of β-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of β-Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: β-Nicotinamide Mononucleotide (NMN) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of β-Nicotinamide Mononucleotide (NMN) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, β-Nicotinamide Mononucleotide (NMN) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Content Greater than or Equal to 98% Major Manufacturers Table 3. Content Less than 98% Major Manufacturers Table 4. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Health Care Products Major Manufacturers Table 6. Cosmetics Major Manufacturers Table 7. Others Major Manufacturers Table 8. β-Nicotinamide Mononucleotide (NMN) Industry Trends Table 9. β-Nicotinamide Mononucleotide (NMN) Industry Drivers Table 10. β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges Table 11. β-Nicotinamide Mononucleotide (NMN) Industry Restraints Table 12. Global β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 13. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026) & (Kg) Table 14. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032) & (Kg) Table 15. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2026) Table 16. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2027-2032) Table 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2026) Table 21. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2027-2032) Table 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 23. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg) Table 24. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032) & (Kg) Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026) Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2027-2032) Table 27. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026) Table 31. Global β-Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 32. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application Table 35. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global β-Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 39. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 40. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026) Table 41. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2027-2032) Table 42. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 43. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026) Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2027-2032) Table 46. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2026) & (US$/Kg) Table 47. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2027-2032) & (US$/Kg) Table 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2026) Table 51. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2027-2032) Table 52. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 53. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 54. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026) Table 55. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2027-2032) Table 56. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2026) & (US$/Kg) Table 57. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2027-2032) & (US$/Kg) Table 58. GeneHarbor Company Information Table 59. GeneHarbor Business Overview Table 60. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 62. GeneHarbor Recent Development Table 63. Herbalmax Company Information Table 64. Herbalmax Business Overview Table 65. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 67. Herbalmax Recent Development Table 68. Genex Formulas Company Information Table 69. Genex Formulas Business Overview Table 70. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 72. Genex Formulas Recent Development Table 73. MIRAILAB BIOSCIENCE Inc Company Information Table 74. MIRAILAB BIOSCIENCE Inc Business Overview Table 75. MIRAILAB BIOSCIENCE Inc β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. MIRAILAB BIOSCIENCE Inc β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 77. MIRAILAB BIOSCIENCE Inc Recent Development Table 78. Maac10 Formulas Company Information Table 79. Maac10 Formulas Business Overview Table 80. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 82. Maac10 Formulas Recent Development Table 83. EffePharm Company Information Table 84. EffePharm Business Overview Table 85. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 87. EffePharm Recent Development Table 88. Bontac Company Information Table 89. Bontac Business Overview Table 90. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 92. Bontac Recent Development Table 93. CELFULL Company Information Table 94. CELFULL Business Overview Table 95. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 97. CELFULL Recent Development Table 98. Kingdomway Company Information Table 99. Kingdomway Business Overview Table 100. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 102. Kingdomway Recent Development Table 103. Oriental Yeast Company Information Table 104. Oriental Yeast Business Overview Table 105. Oriental Yeast β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Oriental Yeast β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 107. Oriental Yeast Recent Development Table 108. Blue California (Conagen) Company Information Table 109. Blue California (Conagen) Business Overview Table 110. Blue California (Conagen) β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Blue California (Conagen) β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 112. Blue California (Conagen) Recent Development Table 113. Borealis Pharma B.V. (Longevir®) Company Information Table 114. Borealis Pharma B.V. (Longevir®) Business Overview Table 115. Borealis Pharma B.V. (Longevir®) β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Borealis Pharma B.V. (Longevir®) β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 117. Borealis Pharma B.V. (Longevir®) Recent Development Table 118. Hi-Tech Pharmaceuticals Company Information Table 119. Hi-Tech Pharmaceuticals Business Overview Table 120. Hi-Tech Pharmaceuticals β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Hi-Tech Pharmaceuticals β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 122. Hi-Tech Pharmaceuticals Recent Development Table 123. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 124. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 125. North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 126. North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 127. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 128. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 129. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 130. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 131. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 132. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 133. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 134. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 135. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 139. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 140. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 141. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 142. North America β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 143. United States β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 144. Canada β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 145. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 146. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 149. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 150. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 151. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 152. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 155. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 156. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 157. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 158. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 162. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 163. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 164. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 165. Europe β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 166. Germany β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 167. France β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 168. U.K. β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 169. Italy β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 170. Russia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 171. Spain β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 172. Netherlands β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 173. Switzerland β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 174. Sweden β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 175. Poland β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 176. China β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 177. China β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 178. China β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 179. China β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 180. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 181. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 182. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 183. China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 184. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 185. China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 186. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 187. China β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 188. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 191. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 192. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 193. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 194. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 197. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 198. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 199. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 200. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 204. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 205. Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 206. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 207. Asia β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 208. Japan β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 209. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 210. India β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 211. Australia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 212. Taiwan β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 214. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 217. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 218. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 219. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 220. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 223. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 224. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 225. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 226. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 230. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 231. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 232. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 233. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 234. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 235. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 236. Chile β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 237. Colombia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 238. Peru β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 240. Israel β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 241. UAE β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 242. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 243. Iran β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 244. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. β-Nicotinamide Mononucleotide (NMN) Distributors List Table 248. β-Nicotinamide Mononucleotide (NMN) Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Image Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure . Content Greater than or Equal to 98% Image Figure 1. Content Less than 98% Image Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Health Care Products Image Figure 5. Cosmetics Image Figure 6. Others Image Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Capacity, Capacity Utilization (2021-2032) & (Kg) Figure 8. Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 9. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2025 Versus 2032 Figure 10. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032) Figure 11. North America β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 12. Europe β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 13. China β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 14. Japan β-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Figure 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032) Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales (2021-2032) & (Kg) Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032) Figure 23. North America β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 24. Europe β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 25. China β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 26. Asia (Excluding China) β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 27. South America, Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2032) Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2032) Figure 33. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032) Figure 34. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032) Figure 35. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 37. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 38. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 39. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 40. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 44. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 45. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 46. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 47. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 48. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 49. China β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 50. China β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 51. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 52. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 53. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 54. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 55. Asia β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 56. Asia β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 57. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 58. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 59. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 60. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 61. SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 62. SAMEA β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 63. β-Nicotinamide Mononucleotide (NMN) Value Chain Figure 64. Manufacturing Cost Structure Figure 65. β-Nicotinamide Mononucleotide (NMN) Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Content Greater than or Equal to 98%
  • Content Less than 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • MIRAILAB BIOSCIENCE Inc
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway
  • Oriental Yeast
  • Blue California (Conagen)
  • Borealis Pharma B.V. (Longevir®)
  • Hi-Tech Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 β-Nicotinamide Mononucleotide (NMN) Market by Type
  3. 1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Content Greater than or Equal to 98%
  5. 1.2.3 Content Less than 98%
  6. 1.3 β-Nicotinamide Mononucleotide (NMN) Market by Application
  7. 1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Health Care Products
  9. 1.3.3 Cosmetics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 β-Nicotinamide Mononucleotide (NMN) Market Dynamics
  1. 2.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 2.2 β-Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 2.3 β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 2.4 β-Nicotinamide Mononucleotide (NMN) Industry Restraints
3 Global β-Nicotinamide Mononucleotide (NMN) Production Overview
  1. 3.1 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2021-2032)
  2. 3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global β-Nicotinamide Mononucleotide (NMN) Production by Region
  4. 3.3.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026)
  5. 3.3.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032)
  6. 3.3.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region
  3. 4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026)
  5. 4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032)
  6. 4.2.4 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032)
  7. 4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region
  9. 4.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026)
  11. 4.4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032)
  12. 4.4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
  2. 5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
  6. 5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global β-Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
  13. 5.7 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global β-Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
  16. 5.8.2 2025 β-Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3
6 β-Nicotinamide Mononucleotide (NMN) Market by Type
  1. 6.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type
  2. 6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2032)
  4. 6.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Type
  5. 6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032) & (Kg)
  6. 6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2032)
  7. 6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type
7 β-Nicotinamide Mononucleotide (NMN) Market by Application
  1. 7.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application
  2. 7.1.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032)
  4. 7.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application
  5. 7.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032) & (Kg)
  6. 7.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032)
  7. 7.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application
8 Company Profiles
  1. 8.1 GeneHarbor
  2. 8.1.1 GeneHarbor Company Information
  3. 8.1.2 GeneHarbor Business Overview
  4. 8.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  6. 8.1.5 GeneHarbor Recent Developments
  7. 8.2 Herbalmax
  8. 8.2.1 Herbalmax Company Information
  9. 8.2.2 Herbalmax Business Overview
  10. 8.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  12. 8.2.5 Herbalmax Recent Developments
  13. 8.3 Genex Formulas
  14. 8.3.1 Genex Formulas Company Information
  15. 8.3.2 Genex Formulas Business Overview
  16. 8.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  18. 8.3.5 Genex Formulas Recent Developments
  19. 8.4 MIRAILAB BIOSCIENCE Inc
  20. 8.4.1 MIRAILAB BIOSCIENCE Inc Company Information
  21. 8.4.2 MIRAILAB BIOSCIENCE Inc Business Overview
  22. 8.4.3 MIRAILAB BIOSCIENCE Inc β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 MIRAILAB BIOSCIENCE Inc β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  24. 8.4.5 MIRAILAB BIOSCIENCE Inc Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 EffePharm
  32. 8.6.1 EffePharm Company Information
  33. 8.6.2 EffePharm Business Overview
  34. 8.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  36. 8.6.5 EffePharm Recent Developments
  37. 8.7 Bontac
  38. 8.7.1 Bontac Company Information
  39. 8.7.2 Bontac Business Overview
  40. 8.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  42. 8.7.5 Bontac Recent Developments
  43. 8.8 CELFULL
  44. 8.8.1 CELFULL Company Information
  45. 8.8.2 CELFULL Business Overview
  46. 8.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  48. 8.8.5 CELFULL Recent Developments
  49. 8.9 Kingdomway
  50. 8.9.1 Kingdomway Company Information
  51. 8.9.2 Kingdomway Business Overview
  52. 8.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  54. 8.9.5 Kingdomway Recent Developments
  55. 8.10 Oriental Yeast
  56. 8.10.1 Oriental Yeast Company Information
  57. 8.10.2 Oriental Yeast Business Overview
  58. 8.10.3 Oriental Yeast β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Oriental Yeast β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  60. 8.10.5 Oriental Yeast Recent Developments
  61. 8.11 Blue California (Conagen)
  62. 8.11.1 Blue California (Conagen) Company Information
  63. 8.11.2 Blue California (Conagen) Business Overview
  64. 8.11.3 Blue California (Conagen) β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Blue California (Conagen) β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  66. 8.11.5 Blue California (Conagen) Recent Developments
  67. 8.12 Borealis Pharma B.V. (Longevir®)
  68. 8.12.1 Borealis Pharma B.V. (Longevir®) Company Information
  69. 8.12.2 Borealis Pharma B.V. (Longevir®) Business Overview
  70. 8.12.3 Borealis Pharma B.V. (Longevir®) β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Borealis Pharma B.V. (Longevir®) β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  72. 8.12.5 Borealis Pharma B.V. (Longevir®) Recent Developments
  73. 8.13 Hi-Tech Pharmaceuticals
  74. 8.13.1 Hi-Tech Pharmaceuticals Company Information
  75. 8.13.2 Hi-Tech Pharmaceuticals Business Overview
  76. 8.13.3 Hi-Tech Pharmaceuticals β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Hi-Tech Pharmaceuticals β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  78. 8.13.5 Hi-Tech Pharmaceuticals Recent Developments
9 North America
  1. 9.1 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 9.1.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 9.1.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 9.1.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 9.2 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 9.2.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 9.2.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 9.2.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 9.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 9.3.1 North America β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 10.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 10.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 10.1.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 10.2 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 10.2.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 10.2.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 10.2.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 10.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 10.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China β-Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 11.1.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 11.1.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 11.1.3 China β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 11.2 China β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 11.2.1 China β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 11.2.2 China β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 11.2.3 China β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 12.1.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 12.1.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 12.1.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 12.2 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 12.2.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 12.2.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 12.2.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 12.3 Asia β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 12.3.1 Asia β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 13.1.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 13.1.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 13.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 13.2.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 13.2.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 13.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 13.3.1 SAMEA β-Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA β-Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 β-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 14.1.1 β-Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 β-Nicotinamide Mononucleotide (NMN) Production Mode & Process
  6. 14.2 β-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 β-Nicotinamide Mononucleotide (NMN) Distributors
  9. 14.2.3 β-Nicotinamide Mononucleotide (NMN) Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst